PAX3 and lung carcinoma: Treatment of lung carcinoma cells transfected with a PAX3 expression plasmid with cycloheximide suggested that Pax3 stimulates p53 degradation [31], however, whether synthesis of p53 or synthesis of a regulator of p53 turnover was also inhibited by cyclohexamide was not determined.